Antony D. Ho

1.8k total citations
7 papers, 214 citations indexed

About

Antony D. Ho is a scholar working on Molecular Biology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Antony D. Ho has authored 7 papers receiving a total of 214 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 2 papers in Genetics and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Antony D. Ho's work include Angiogenesis and VEGF in Cancer (2 papers), Lymphoma Diagnosis and Treatment (2 papers) and Urinary Tract Infections Management (1 paper). Antony D. Ho is often cited by papers focused on Angiogenesis and VEGF in Cancer (2 papers), Lymphoma Diagnosis and Treatment (2 papers) and Urinary Tract Infections Management (1 paper). Antony D. Ho collaborates with scholars based in Germany. Antony D. Ho's co-authors include Sascha Dietrich, Hartmut Goldschmidt, Mathias Witzens‐Harig, Heinrich K. Geiss, Hans Salwender, Gerlinde Egerer, Stefan Schönland, Arnt V. Kristen, Ute Hegenbart and Jörg Beimler and has published in prestigious journals such as Blood, Cancer and Head & Neck.

In The Last Decade

Antony D. Ho

7 papers receiving 209 citations

Peers

Countries citing papers authored by Antony D. Ho

Since Specialization

Citations

This map shows the geographic impact of Antony D. Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antony D. Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antony D. Ho more than expected).

Fields of papers citing papers by Antony D. Ho

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antony D. Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antony D. Ho. The network helps show where Antony D. Ho may publish in the future.

Co-authorship network of co-authors of Antony D. Ho

This figure shows the co-authorship network connecting the top 25 collaborators of Antony D. Ho. A scholar is included among the top collaborators of Antony D. Ho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antony D. Ho. Antony D. Ho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

#	Work	Indexed citations
1	Two cycles of risk-adapted consolidation therapy in patients with acute promyelocytic leukemia. Results from the SAL-AIDA2000 trial 2014 ·Annals of Hematology ·Christoph Röllig, (unknown), Matthias Hänel, Michael Krämer, Markus Schaich, Christian Thiede, Uta Oelschlägel, Brigitte Mohr, Thomas Wagner, Hermann Einsele, Stefan W. Krause, H. Bodenstein, Sonja Martin, Reingard Stuhlmann, Antony D. Ho, Martin Bornhäuser, Gerhard Ehninger, Ulrich S. Schuler, Uwe Platzbecker	5
2	Replacement of conventional doxorubicin by pegylated liposomal doxorubicin is a safe and effective alternative in the treatment of non-Hodgkin's lymphoma patients with cardiac risk factors 2011 ·Annals of Hematology ·(unknown), Sascha Dietrich, Antony D. Ho, Mathias Witzens‐Harig	25
3	Patterns and outcome of relapse after autologous stem cell transplantation for mantle cell lymphoma 2010 ·Cancer ·Sascha Dietrich, (unknown), Michael A. Rieger, Maike Nickelsen, Christiane Pott, Mathias Witzens‐Harig, Michael Kneba, Norbert Schmitz, Antony D. Ho, Peter Dreger	31
4	Treatment with intravenous melphalan and dexamethasone is not able to overcome the poor prognosis of patients with newly diagnosed systemic light chain amyloidosis and severe cardiac involvement 2010 ·Blood ·Sascha Dietrich, Stefan Schönland, Axel Benner, Tilmann Bochtler, Arnt V. Kristen, Jörg Beimler, Ernst Hund, Markus Zorn, Hartmut Goldschmidt, Antony D. Ho, Ute Hegenbart	67
5	Chlorhexidine and silver-sulfadiazine coated central venous catheters in haematological patients—a double-blind, randomised, prospective, controlled trial 2005 ·Supportive Care in Cancer ·(unknown), (unknown), (unknown), Hans Salwender, Gerlinde Egerer, Heinrich K. Geiss, Antony D. Ho, Hartmut Goldschmidt	62
6	Prognostic relevance of serum levels of the angiogenic peptide bFGF in advanced carcinoma of the head and neck treated by primary radiochemotherapy 2000 ·Head & Neck ·Andreas Dietz, Volker Rudat, Christian Conradt, H. Weidauer, Antony D. Ho, Thomas Moehler	23
7	Prognostic relevance of serum levels of the angiogenic peptide bFGF in advanced carcinoma of the head and neck treated by primary radiochemotherapy 2000 ·Head & Neck ·Andreas Dietz, Volker Rudat, Christian Conradt, H. Weidauer, Antony D. Ho, Thomas Moehler	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact